Literature DB >> 28526155

Ketorolac, Oxymorphone, Tapentadol, and Tramadol: A Comprehensive Review.

Nalini Vadivelu1, Daniel Chang2, Erik M Helander3, Gregory J Bordelon3, Alice Kai2, Alan D Kaye3, Dora Hsu4, Daniel Bang4, Inderjeet Julka4.   

Abstract

Pain remains a tremendous burden on patients and for the health care system, with uncontrolled pain being the leading cause of disability in this country. There are a variety of medications that can be used in the treatment of pain, including ketorolac, oxymorphone, tapentadol, and tramadol. Depending on the clinical situation, these drugs can be used as monotherapy or in conjunction with other types of medications in a multimodal approach. A strong appreciation of pharmacologic properties of these agents and potential side effects is warranted for clinicians.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Analgesia; Ketorolac; Oxymorphone; Pain; Tapentadol; Tramadol

Mesh：

Substances：

Year:  2017        PMID： 28526155     DOI： 10.1016/j.anclin.2017.01.001

Source DB:  PubMed          Journal:  Anesthesiol Clin        ISSN： 1932-2275


  5 in total

Review 1.  Perioperative Pain Management and Opioid Stewardship: A Practical Guide.

Authors:  Sara J Hyland; Kara K Brockhaus; William R Vincent; Nicole Z Spence; Michelle M Lucki; Michael J Howkins; Robert K Cleary
Journal:  Healthcare (Basel)       Date:  2021-03-16

2.  Phytochemical Analysis and Evaluation of the Antioxidant, Anti-Inflammatory, and Antinociceptive Potential of Phlorotannin-Rich Fractions from Three Mediterranean Brown Seaweeds.

Authors:  Amal Abdelhamid; Meriem Jouini; Haifa Bel Haj Amor; Zeineb Mzoughi; Mehdi Dridi; Rafik Ben Said; Abderrahman Bouraoui
Journal:  Mar Biotechnol (NY)       Date:  2018-01-18       Impact factor: 3.619

3.  Pharmacokinetics and Bioequivalence Evaluation of a New Oxycodone Tamper-Resistant Tablet Administered with an Opioid Antagonist in Patients with Chronic Pain.

Authors:  Zhu Luo; Jia Miao; Shiqing Shu; Ying Wang; Xiaohong Zhu; Chao Hu; Yali Shen
Journal:  Clin Drug Investig       Date:  2020-02       Impact factor: 2.859

4.  Comparison of different sufentanil-tramadol combinations for pain relief within the first 24 hours after cesarean section: a retrospective study.

Authors:  Xueqin Cao; Xianwei Zhang
Journal:  J Pain Res       Date:  2018-10-23       Impact factor: 3.133

5.  Evaluation of Abuse and Route of Administration of Extended-Release Tapentadol Among Treatment-Seeking Individuals, as Captured by the Addiction Severity Index-Multimedia Version (ASI-MV).

Authors:  Suzanne K Vosburg; Jared Beaumont; S Taryn Dailey-Govoni; Stephen F Butler; Jody L Green
Journal:  Pain Med       Date:  2020-09-01       Impact factor: 3.750
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.